Recent Company News

• 02:23 AM ET Apr 29, 2025
  

  Xvivo Perfusion announces 12-month follow-up results from European multicenter heart trial, NIHP2019, was presented at the 2025 ISHLT Annual Meeting in Boston, USA (SEK 300.00, 0.00)

• 02:55 AM ET Apr 25, 2025
  

  Xvivo Perfusion upgraded to hold from sell at Danske Bank (SEK 313.80, 0.00)

• 03:58 AM ET Jan 28, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:42 AM ET Apr 24, 2025
  

  Xvivo Perfusion reports Q1 EPS (SEK0.39) vs FactSet SEK0.79 [3 est, SEK0.50-0.95] (SEK 293.60, 0.00)

• 04:10 AM ET Apr 07, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (411 total)

• 01:31 PM ET Mar 25, 2025
  

  Xvivo Perfusion upgraded to buy from hold at Pareto

• 03:49 AM ET Mar 25, 2025
  

  Xvivo Perfusion downgraded to sell from buy at Danske Bank (SEK 381.00, 0.00)

• 02:58 AM ET Jan 28, 2025
  

  StreetAccount Summary - European pre-market trading update